Insider Transactions in Q2 2025 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2025
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+9.27%
|
-
|
|
Jun 05
2025
|
Rifat Pamukcu Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+16.1%
|
-
|
|
Jun 05
2025
|
Richard Peters Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+25.1%
|
-
|
|
Jun 05
2025
|
Bernd R. Seizinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+2.23%
|
-
|
|
Jun 05
2025
|
Jean Pierre Bizzari Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+50.0%
|
-
|
|
Jun 05
2025
|
Marc Duey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+0.44%
|
-
|
|
Jun 05
2025
|
Michael Grissinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+26.56%
|
-
|
|
Jun 05
2025
|
Gabriela Gruia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+50.0%
|
-
|
|
Apr 03
2025
|
Oren Gilad President/CEO |
BUY
Open market or private purchase
|
Direct |
5,500
+0.79%
|
$5,500
$1.84 P/Share
|